Drug
Dinutuximab Beta
Dinutuximab Beta: highest development phase Phase 2, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Dinutuximab Beta, Zoledronic acid, Interleukin-2 NCT05080790 | Phase 2 | Leiomyosarcoma |
Latest
No recent events.
Follow Dinutuximab Beta on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.